Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Enabling AI to Drive Innovation and Precision across Oncology R&D
0
Zitationen
5
Autoren
2026
Jahr
Abstract
The use of integrated large-scale, multidomain datasets with artificial intelligence (AI) is now essential in drug discovery and development. Organizations that strategically invest in robust data infrastructure and fit-for-purpose AI solutions will accelerate the delivery of precision oncology therapeutics globally.
Ähnliche Arbeiten
Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI
2019 · 8.700 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.605 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 8.133 Zit.
BioBERT: a pre-trained biomedical language representation model for biomedical text mining
2019 · 6.873 Zit.
Proceedings of the 19th International Joint Conference on Artificial Intelligence
2005 · 5.781 Zit.